Biobanking as a Newsletter – November 19

Have you seen the David Letterman’s interview of Bollywood star Shah Rukh Khan on Netflix? If not, it is worth watching to get a sneak peek into India and the life of a Bollywood star. While I never liked his movies, I always found his life story to be inspiring. If you happen to watch it, do let me know what you think.

And also we bring to you the monthly curated pick of biobanking news, jobs, and events from across the globe. 

Case Study: Why TTAB at University of Pennsylvania adopted OpenSpecimen?

Fresh of the Press:

  • The University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy
  • NIH grant to study unstructured data that can improve patient safety
  • New therapy at Morristown Medical Center uses the patient’s own immune cells to fight their cancer
  • Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank
  • Crohn’s & Colitis Foundation picked for FDA’s MyStudies project
  • Precision medicine research and biobanking in China
  • Next-generation biobanking and cell culture technology for pathophysiologically relevant in vitro tumor models
  • Taiwan to integrate 31 biobanks across the nation in the hope of accelerating disease research and the development of new drugs
  • Apple launches three innovative studies today in the new Research app
  • ISBER welcomes the submission of late-breaking abstracts in fields related to the use of environmental and biological repositories. The deadline for submission is December 23, 2019. 

Biobank Job Alerts 

Upcoming Events

OpenSpecimen News

Posters at ABNA and ISBER: OpenSpecimen News

New Feature Highlights: 

OSCON19: USA

We just concluded our “Community Meet” in Miami, USA. A big thanks to all our adopters for participating and making the meeting successful.

OSCON19 (Miami, USA)

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.